October 1, 2024–Celebrate the magnificence of horses during Horse Week 2024, an online film festival proudly presented by ...

One of the primary factors fueling the growth of the DOACs market is the rapid uptake and expected utilization within the ...

A comprehensive EU-wide mental health strategy is essential to tackle the region’s growing mental health crisis. Prioritising ...

In 2023, the market is anticipated to be valued at USD 26.64 Billion, marking a significant starting point for a decade-long ...

Boehringer Ingelheim & WHO Foundation join forces to promote equitable access to healthcare and increase efforts for suicide prevention: Ingelheim, Germany Wednesday, October 16, ...

Boehringer Ingelheim and Circle Pharma Announce New Research Collaboration to Develop a Novel Precision Cancer Treatment ...

Earlier this year, pharmaphorum spoke with Boehringer Ingelheim’s Nedim Pipic, corporate SVP and therapeutic area head of CNS, retinopathies, and emerging areas, and Prof Thomas Schulze ...

Boehringer Ingelheim partners with the WHO Foundation to financially support WHO’s Fourteenth General Programme of Work (2025 to 2028). Credit: PeopleImages.com – Yuri A/Shutterstock. Boehringer ...

Boehringer Ingelheim’s Ulrike Graefe-Mody on her career path; Driving launch excellence; Top trends coming out of ESMO 2024 ...

Enter the extraordinary Marlene Engelhorn, 32, an Austrian heiress to the Boehringer Mannheim fortune. When she inherited the equivalent of more than $27 million, she pledged to give it away—not ...

Boehringer’s Medicine Excellence initiative harnesses technology with the aim to build a ‘One Medicine Platform’, unifying development processes and data in a centralised platform.